Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Alembic Pharmaceuticals Ltd.
NSE: APLLTD
|
BSE: 533573
|
ISIN: INE901L01018
|
Industry: Pharmaceuticals
|
Expensive Performer
1006.5500
17.60
(
1.78
%)
NSE
May 29, 2025
15:31 PM
38.80% Gain from 52W Low
Volume:
78,557
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alembic Pharmaceuticals Ltd.
24 Jan 2020
1006.55
1.78%
Alembic Pharmaceuticals Ltd: Results Outperform Due to Sartan Supply Opportunities
Hold:
Alembic Pharmaceuticals Ltd.
by
Karvy
Target: 3
Target
Karvy
In Q3FY20, total revenues of Alembic Pharma increased by 18.7percent YoY toRs. 12.1 bn.
Alembic Pharmaceuticals Ltd. is trading
below its 200 day SMA
of 1007.5
More from Alembic Pharmaceuticals Ltd.
Recommended
Market closes higher, Alkem Labs' Q4 net profit rises 4.2% YoY to Rs 305.9 crore
Trendlyne Marketwatch |
29 May 2025, 04:09PM
Nifty 50’s annual winners: Top-performing stocks of the past decade
The Baseline |
29 May 2025, 01:00PM
Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals
|
22 Jul 2020